Browse Articles
Discover research articles across all indexed journals
A systematic review and meta-analysis of psychological treatments to improve sleep quality in university students
Objective This paper reviews the literature evaluating psychological treatments to improve sleep quality in young adult university students. Method Participants (N = 6179) were young adult (aged 18–30 years) university students. Databases (PubMed, PsychInfo, EMBASE and Medline) were searched for randomized controlled trials evaluating psychological treatments for sleep disturbance in university students. The search date was 20 September 2024. Results 22 original trials met inclusion criteria. Meta-analysis showed that psychological interventions outperformed control groups (n = 14) on improving sleep quality (g = 0.50, 95%CI:0.26–0.73). There were significantly different effect sizes found between studies that evaluated cognitive behaviour therapy for insomnia (CBT-I; n = 6, g = 0.72, CI: 0.43–1.02) versus studies that evaluated mindfulness interventions (n = 5, g = 0.16, 95% CI: -0.18–0.51). Conclusions Psychological treatments improve sleep quality for young adult university students. While CBT-I showed larger effect sizes than interventions focused on mindfulness, further research is needed to verify if this reflects a true difference in the efficacy of the interventions.
Sex and age differences in cardiovascular risk factors and lifestyle in patients recently diagnosed with diabetes mellitus: A cross-sectional study in Spanish primary health care
Aims To describe the main characteristics of patients recently diagnosed with DM regarding cardiovascular risk factors and diabetes-related complications, compare possible differences according to sex and age group, and examine healthy lifestyle behaviors such as adherence to the Mediterranean diet and physical activity and their associated factors. Methods A cross-sectional, multicenter, observational study of 681 patients aged >30 years diagnosed with diabetes mellitus in the previous 4 years was performed. The patients were treated in primary care centers in Madrid (Spain). The variables were obtained from their electronic medical records, physical examination, complete analysis, and lifestyle questionnaires. Results The main comorbidities were: hypercholesterolemia (64.4%; 95% CI, 60.6–68.2), hypertension (55.2%; 95% CI, 51.3–59.1), obesity (58.9%; 95% CI, 55.2–62.6), metabolic syndrome (58.5%; 95% CI, 54.6–62.5); and hypertriglyceridemia (25.3%; 95% CI, 21.9–28.7). Despite being newly diagnosed, 7.6% (95% CI, 5.4–9.8) had microalbuminuria, and 10.3% (95% CI, 8.0–12.6) cardiovascular disease. The main unhealthy lifestyles were: low physical activity (52%; 95% CI, 48.1–55.9), alcohol consumption (47.7%; 95% CI, 44.0–51.5) and smoking (19.2%; 95% CI, 16.2–22.3). Compared with men, women had more morbid obesity (9.7% vs 4.6%, p = .014), worse lipid profile (total cholesterol: 184 (IQR, 158–207) vs. 165 (IQR, 144–192), p < .01), less treatment with metformin (74.8% vs. 84.4%, p < .01) and antiplatelet agents (8.1% vs.18.6%, p < .01), but women had fewer comorbidities. Patients with a high educational level (OR = 1.90, 95% CI, 1.28–2.81)) and those >60 years (OR = 1.49; 95% CI, 1.01–2.21) were more adherent to the Mediterranean diet, and the older ones did less intense exercise (OR = 0.34, 95% CI, 0.16–0.75). Normal blood pressure was associated with Mediterranean diet (OR = 1.52; 95% CI, 1.05–2.21) and high physical activity (OR = 4.03; 95% CI, 1.69–9.61); and body mass index was inversely associated with physical activity (OR = 0.92; 95% CI, 0.85–0.99). Conclusions Patients newly diagnosed with diabetes mellitus may also have crucial cardiovascular risk factors and comorbidities at the onset of the disease. However, patients with a healthy lifestyle were more likely to have a normal blood pressure and a lower body mass index.
Heme promotes venetoclax resistance in multiple myeloma through MEK-ERK signaling and purine biosynthesis
Abstract We previously demonstrated that reduced intrinsic electron transport chain (ETC) activity predicts and promotes sensitivity to the B-cell lymphoma 2 (BCL-2) antagonist, venetoclax (Ven), in multiple myeloma (MM). Heme, an iron-containing prosthetic group and metabolite, is fundamental to maintaining ETC activity. Interrogation of the cyclin D1 group 2 subgroup of MM from the Relating Clinical Outcomes in MM to Personal Assessment of Genetic Profile (CoMMpass) trial (NCT01454297), which can be used as a proxy for Ven-sensitive MM (VS MM), shows reduced expression of the conserved heme biosynthesis pathway gene signature. Consistent with this, we identified that VS MM exhibits reduced heme biosynthesis and curiously elevated hemin (oxidized heme) uptake. Supplementation with hemin or protoporphyrin IX (heme lacking iron) promotes Ven resistance, whereas targeting ferrochetalase, the penultimate enzyme involved in heme biosynthesis, increases Ven sensitivity in cell lines and primary MM cells. Mechanistically, heme-mediated activation of prosurvival rapidly accelerated fibrosarcoma-rat sarcoma virus–mitogen-activated protein kinase (MEK) signaling and metabolic rewiring, increasing de novo purine synthesis, were found to contribute to heme-induced Ven resistance. Cotargeting BCL-2 and myeloid cell leukemia-1 suppresses heme-induced Ven resistance. Interrogation of the Multiple Myeloma Research Foundation CoMMpass study of patients shows increased purine and pyrimidine biosynthesis to corelate with poor progression-free survival and overall survival. Elevated heme and purine biosynthesis gene signatures were also observed in matched relapse refractory MM, underscoring the relevance of heme metabolism in therapy-refractory MM. Overall, our findings reveal, for the first time, a role for extrinsic heme, a physiologically relevant metabolite, in modulating proximity to the apoptotic threshold with translational implications for BCL-2 antagonism in MM therapy.
Image captioning in Bengali language using visual attention
Automatically generating image captions poses one of the most challenging applications within artificial intelligence due to its integration of computer vision and natural language processing algorithms. This task becomes notably more formidable when dealing with a language as intricate as Bengali and the overall scarcity of Bengali-captioned image databases. In this investigation, a meticulously human-annotated dataset of Bengali captions has been curated specifically for the encompassing collection of pictures. Simultaneously, an innovative end-to-end architecture has been introduced to craft pertinent image descriptions in the Bengali language, leveraging an attention-driven decoder. Initially, the amalgamation of images’ spatial and temporal attributes is facilitated by Gated Recurrent Units, constituting the input features. These features are subsequently fed into the attention layer alongside embedded caption features. The attention mechanism scrutinizes the interrelation between visual and linguistic representations, encompassing both categories of representations. Later, a comprehensive recursive unit comprising two layers employs the amalgamated attention traits to construct coherent sentences. Utilizing our furnished dataset, this model undergoes training, culminating in achievements of a 43% BLEU-4 score, a 39% METEOR score, and a 47% ROUGE score. Compared to all preceding endeavors in Bengali image captioning, these outcomes signify the pinnacle of current attainable standards.
Acute erythroid leukemia or acute myeloid leukemia with mutated <i>TP53</i>? The battle of phenotype versus genotype
Formulation and evaluation of atorvastatin calcium trihydrate Form I tablets
Solid forms transformations and new crystal structures of an active pharmaceutical ingredient (API) can occur due to various manufacturing process conditions, especially if the drug substance is formulated as a hydrate. The conversion between hydrate and anhydrate forms caused by changes in temperature and humidity must be evaluated because of the risk of dehydration and phase transitions during the manufacturing process. Differences in physicochemical, mechanical, and rheological properties have been observed between solid forms of the same API that can cause manufacturing and product-related issues. Atorvastatin calcium trihydrate (ACT) is a synthetic lipid-lowering agent that was discovered during Lipitor® (its anhydrous form) Phase 3 clinical trials after passing Phase I and II. This case highlights the importance of routinely performing solid form screenings because of the probability of finding new solid forms during the development and scale-up process. Therefore, in this contribution, ACT tablet formulation was performed and evaluated starting from the compatibility of 1:1 proportions of drug and the excipients microcrystalline cellulose 101 (MCC 101), calcium carbonate, lactose monohydrate, croscarmellose sodium, hydroxypropyl cellulose, magnesium stearate, and polysorbate 80. Then, 40 mg ACT tablets were prepared on a small pilot scale, and manufacturing process assessment was conducted by sampling process stages selected as critically prone to solid forms formation or phase transition. Final product quality was evaluated regarding weight variation, hardness, disintegration, dissolution, and assay tests. Powder X-ray diffraction (PXRD), Fourier transform infrared spectroscopy (FT-IR), differential scanning calorimetry (DSC), and thermogravimetric analysis (TGA) were applied to solid state evaluation. The starting raw material was confirmed to be ACT Form I. From the preformulation studies, PXRD, FT-IR and TGA analyses showed no interactions between ACT and excipients, while DSC results revealed a physical interaction with MCC 101, not considered an incompatibility. The effect of the tablet manufacturing process was achieved by amorphization, while some ACT long-range crystalline structure remained, as confirmed by PXRD, FT-IR and DSC. However, the tablets’ quality parameters were found to be within the acceptable range of both the pharmacopeia guidelines and manufacturer parameters regarding weight variation, hardness, disintegration, dissolution, and assay tests.
Introduction to a review series on mantle cell lymphoma: sands shifting in the darkness
Mantle cell lymphoma (MCL) is a rare and aggressive form of non-Hodgkin B-cell lymphoma that defies cures in most patients. Over the last decade, significant advances have been made in our understanding of the biology of the disease, patient risk stratification, and novel therapies. Associate Editor Philippe Armand presents a series of reviews that provide advice on management of patients, illuminate current understanding of the molecular landscape associated with the disease, and how that may shape future research and care. Ryan et al review the current frontline management of MCL in a rapidly evolving field, underscoring ongoing phase 3 trials; Silkenstedt and Dreyling highlight the emerging treatments for relapsed and refractory MCL; Jain and Wang tackle the critical issue of risk assignment based on clinical and molecular features; and Sarkozy and colleagues explore in depth the biology of MCL with an emphasis not only on intrinsic vulnerabilities but also on the tumor microenvironment.
You can’t see what you don’t measure! A scoping review of measurements of gender-based violence, its determinants and consequences in academia
Introduction Assessing the problem of gender-based violence in academia internationally is challenging due to a lack of empirical evidence and differences in how it is measured. The contribution of this article is to reflect on survey measurements and to propose new avenues for future quantitative measurements of gender-based violence, its determinants, and consequences in an academic context. For this purpose, we present the results of a scoping review of ten national and cross-national prevalence studies on gender-based violence. We examined the studies’ quantitative operationalisation of (1) sex and gender, (2) prevalence of gender-based violence, (3) socio-demographic determinants from an intersectional perspective, individual and contextual factors, (4) and consequences. Materials and methods Prevalence studies were identified through a comprehensive search of electronic databases and specialised data repositories. The selection criteria included studies with a focus on gender-based violence, the use of closed-ended survey questions, i.e., in a questionnaire, the potential for applicability in different national contexts, and the specific context of higher education. Eligible sources also described the quantitative operationalisation of the survey measurements. Results Our work critically reviews previous efforts to measure gender-based violence, its determinants, and consequences in academic contexts. The findings of our assessment show, first, that quantitative gender-related measurements tend to conflate the concepts of sex and gender, and hence their operationalisation in quantitative surveys. Second, there is a strong emphasis on sexual harassment and sexual violence to the detriment of other relevant forms of violence, as well as a rooting of measurement concepts in locally valid but diverse legal definitions of gender-based violence. Third, there is a lack of socio-demographic determinants to provide an intersectional lens, as well as a focus on measurement frameworks that individualise the experiences of gender-based violence. This prevents a conceptualisation of harassment and abuse as a structural problem in the academic sector and ignores that violence is both as a cause and a consequence of unbalanced gendered power relations and inequalities in institutional and societal contexts. Fourth, there is generally a retrospective approach to measuring the consequences of gender-based violence, which may represent a source of potential bias. We reflect on how future survey instruments could address these issues in academic environments. Discussion Overall, our paper demonstrates how the evidence generated by different conceptualisations and operationalisations of gender-based violence in academia, as well as its determinants and consequences, shapes how we think and talk about the problem. In doing so, this article contributes to the ongoing methodological discussion on the measurement of gender-based violence and provides a rationale for improving its measurement framework in academic environments by taking a feminist-theory informed approach to collecting these data.
Sequential epigenetic therapy in AML
Experiences of rehabilitation one year after breast cancer diagnosis–A focus group study from the ReScreen randomized controlled trial
Background Treatment for breast cancer poses major challenges and leads to a variety of side-effects and problems that affect life for a long time. Experiences and symptoms vary, and research indicates a lack of structures for ensuring individualized rehabilitation. This qualitative focus group study aims to explore the experience of women with BC after participating in a complex randomized controlled trial (RCT) (Clinicaltrials.gov NCT03434717) focusing on cancer rehabilitation from a comprehensive perspective. Method Nine semi-structured focus group interviews with women (n = 30) who participated in the Rescreen RCT were conducted. The women were interviewed divided into three RCT groups (intervention, control, or observation group). Data were initially analyzed inductively using conventional content analysis, followed by a deductive approach, guided by the result from the inductive analysis. Results The inductive analysis resulted in two categories and four sub-categories and showed a great variation in experiences and needs. Some women described a well-functioning process, while others described lack of individualized information, continuity with healthcare providers, and clear pathways for support. After the deductive analysis, a variation between the groups appeared. Women in the intervention group expressed that a proactive and individualized approach facilitated rehabilitation and they experienced a feeling of being recognized as a person, which they highlighted as important. On the contrary, women from the control group described feelings of being abandoned from healthcare, hindering rehabilitation. The observation group expressed that their needs had been fulfilled within the healthcare system. Conclusions This study adds important knowledge to the evaluation of the ReScreen model and contributes to existing research on how individualized rehabilitation after breast cancer can be applied in clinical practice. A proactive, person-centered approach in rehabilitation, aimed at those with extended needs, would potentially optimize rehabilitation and facilitate the recovery process after breast cancer treatment.
Ferroptosis regulates hemolysis in stored murine and human red blood cells
Abstract Red blood cell (RBC) metabolism regulates hemolysis during aging in vivo and in the blood bank. However, the genetic underpinnings of RBC metabolic heterogeneity and extravascular hemolysis at population scale are incompletely understood. On the basis of the breeding of 8 founder strains with extreme genetic diversity, the Jackson Laboratory diversity outbred population can capture the impact of genetic heterogeneity in like manner to population-based studies. RBCs from 350 outbred mice, either fresh or stored for 7 days, were tested for posttransfusion recovery, as well as metabolomics and lipidomics analyses. Metabolite and lipid quantitative trait loci (QTL) mapped &gt;400 gene-metabolite associations, which we collated into an online interactive portal. Relevant to RBC storage, we identified a QTL hotspot on chromosome 1, mapping on the region coding for the ferrireductase 6-transmembrane epithelial antigen of the prostate 3 (Steap3), a transcriptional target to p53. Steap3 regulated posttransfusion recovery, contributing to a ferroptosis-like process of lipid peroxidation, as validated via genetic manipulation in mice. Translational validation of murine findings in humans, STEAP3 polymorphisms were associated with RBC iron content, lipid peroxidation, and in vitro hemolysis in 13 091 blood donors from the Recipient Epidemiology and Donor Evaluation Study. QTL analyses in humans identified a network of gene products (fatty acid desaturases 1 and 2, epoxide hydrolase 2, lysophosphatidylcholine acetyl-transferase 3, solute carrier family 22 member 16, glucose 6-phosphate dehydrogenase, very long chain fatty acid elongase, and phospholipase A2 group VI) associated with altered levels of oxylipins. These polymorphisms were prevalent in donors of African descent and were linked to allele frequency of hemolysis-linked polymorphisms for Steap3 or p53. These genetic variants were also associated with lower hemoglobin increments in thousands of single-unit transfusion recipients from the vein-to-vein database.
Sickness absenteeism among nurses after the COVID-19 pandemic: A study protocol
Introduction Sickness absenteeism among the nurses in Malaysia is not fully understood. Complicated with the increase in workload and mental stress during the COVID-19 pandemic and the manifestation of long COVID-19 symptoms, there is a need for an updated insight on the prevalence and the risk factors of sickness absenteeism among nurses in Malaysia. As such, we designed a study protocol that assess the prevalence and risk factors of sickness absenteeism among nurses in Malaysia in the post-COVID-19 pandemic era. Materials and methods This is a correlational cross-sectional study. The sociodemographic and clinical questionnaire, sickness absenteeism questionnaire, job characteristics questionnaire, Demand-Control-Support Questionnaire (DCSQ), Work-Related Strain Inventory (WRSI), Work and Family Conflict Scale (WAFCS), the COVID-19-related workplace worries questionnaire, as well as the Depression, Anxiety, and Stress (DASS-21) questionnaire will be randomly distributed to 166 nurses from October 2024 to May 2025. Discussion While physical illnesses, psychological disorders, job-related factors, and sociodemographic factors have been identified as risk factors to sickness absenteeism among healthcare professionals in general, the role of these risk factors in causing sickness absenteeism among the nurses remains unclear. Additionally, the increased stress and workload faced by nurses during the COVID-19 pandemic, as well as post-acute COVID-19 syndrome, may have further impacted sickness absenteeism. Conclusion By examining the various risk factors of sickness absenteeism, especially in the post-COVID-19 pandemic era, this research will inform future targeted interventions to reduce sickness absenteeism among Malaysian nurses and its associated consequences.
Mosunetuzumab next up to bat … is it a home run?
From larva to adult: In vitro rearing protocol for honey bee (Apis mellifera) drones
Development of a successful in vitro rearing protocol has been essential for pesticide safety assessment of immature honey bee workers under laboratory conditions. In contrast, pesticide safety testing of honey bee drones is limited, in part due to the lack of successful laboratory rearing protocols for this reproductive caste. Considering that healthy drones are essential for successful mating and reproduction of the honey bee queen, a standardized in vitro rearing protocol for honey bee drones is necessary to support reproductive safety studies, as well as to gain a deeper understanding of honey bee drone development. Using the established in vitro rearing protocol for honey bee workers, we modified the days of grafting and pupal transfer, as well as the diet volume, pupation plate orientation, and absorbent tissue in the pupal wells to successfully rear honey bee drones in vitro. In vitro-reared drones were evaluated for gross wing abnormalities, body weight, testes weight, and abdominal area, and compared with age-matched drones reared in field colonies. We found that honey bee drones reared in a vertically oriented pupation plate containing WypAll® absorbent tissue in each well had a mean survival to adulthood of 74 ± 3.5% (SEM) until adulthood. In contrast, drones reared in a horizontally oriented pupation plate containing Kimwipe® absorbent tissue in each well had significantly lower survival (5.5 ± 2.3%) and demonstrated gross wing abnormalities. All in vitro-reared drones had significantly lower body weight, testes weight and abdominal area relative to colony-reared control drones. Accordingly, we successfully developed an in vitro rearing protocol for honey bee drones which has the potential to improve future reproductive safety assessment of pesticides for honey bees.
Heme fuels venetoclax resistance in multiple myeloma
Investigating the safety of physical rehabilitation with critically ill patients receiving vasoactive drugs: An exploratory observational feasibility study
Background Physical rehabilitation of critically ill patients may improve physical outcomes; however, the relative benefits and risks with patients requiring vasoactive drugs is currently unknown. A feasibility study is needed to inform the design of a future trial required to address this issue. Methods A two-phase exploratory observational feasibility study was carried out: A retrospective study to clarify the current practice of rehabilitation with patients receiving vasoactive drugs to inform future trial interventions and design. A prospective study exploring recruitment and outcome measurement. Intensive care patients receiving vasoactive drugs were recruited and asked about the acceptability of a future trial. The feasibility of using an adverse event tool was measured during rehabilitation. Patients were followed up after 60 days to describe the feasibility of measuring outcomes for a future trial. Results Retrospective study (n = 78): Twenty-one percent of patients took part in physical rehabilitation whilst receiving vasoactive drugs. Of 321 days with vasoactive drugs administered, physical rehabilitation occurred on 27 days (8%). Prospective study (n = 40): Eighty-one percent of participants indicated acceptability of being recruited into a future trial (n = 37). Eighty-eight percent of clinicians found it acceptable to randomise patients into either early rehabilitation or standard care. The adverse event tool was implemented by researchers with 2% loss of information. Finally, a 100% follow-up rate at day 60 was achieved for mortality outcomes. Follow-up rates were 70% for the EQ-5D (5 level), 65% for the World Health Organisation’s Disability Assessment Schedule 2.0 and RAND 36-item Health Survey 1.0 and 26% for the 6-minute walk test. Conclusions This study found a low frequency of physical rehabilitation occurring with intensive care patients receiving vasoactive drugs. A high proportion of clinicians and patients found a future RCT within this patient group acceptable. Mortality and patient-reported outcomes were the most feasible to measure.
Unraveling MCL biology to understand resistance and identify vulnerabilities
Abstract Mantle cell lymphoma (MCL) is a rare (5%-7%), aggressive B-cell non-Hodgkin lymphoma with well-defined hallmarks (eg, cyclin D1, SOX11), and its expansion is highly dependent on the tumor microenvironment (TME). Parallel drastic progress in the understanding of lymphomagenesis and improved treatments led to a paradigm shift in this B-cell malignancy with now prolonged disease-free survival after intensive chemotherapy and anti-CD20-based maintenance. However, this toxic strategy is not applicable in frail or older patients, and a small but significant part of the cases present a refractory disease representing unmet medical needs. Importantly, the field has recently seen the rapid emergence of targeted and immune-based strategies with effective combinations relying on biological rationales to overcome malignant plasticity and intratumor heterogeneity. In this review, we expose how unraveling the biology of MCL allows to better understand the therapeutic resistances and to identify neo-vulnerabilities in tumors, which are essential to offer efficient novel strategies for high-risk patients. We first highlight the tumor intrinsic resistance mechanisms and associated Achilles heels within various pathways, such as NF-κB, mitochondrial apoptosis, DNA repair, and epigenetic regulators. We then place the tumor in its complex ecosystem to decipher the dialog with the multiple TME components and show how the resulting protumoral signals could be disrupted with innovative therapeutic strategies. Finally, we discuss how these progresses could be integrated into a personalized approach in MCL.
The impact of carbohydrate quality on gut health: Insights from the NHANES
Background High- and low-quality carbohydrate diets are linked to gut health. However, their specific relationship with constipation or diarrhea is unclear. This study uses 2005–2010 NHANES data to examine the relationship between carbohydrate quality and constipation and diarrhea, and to identify suitable populations for different carbohydrate diets. Methods Chronic constipation was defined as BSFS types 1 and 2, and chronic diarrhea as types 6 and 7. Dietary intake data were provided by the FPED, using data from the NHANES database. Subjects recalled foods and beverages consumed in the past 24 hours, and intake was averaged and divided into quartiles (Q). After adjusting for covariates, associations between high- and low-quality carbohydrate diets and constipation or diarrhea were assessed using weighted RCS curves and multivariate logistic regression. Results were expressed as weighted ORs and 95% CIs, with subgroup analyses performed. Results A total of 11,355 people participated, with 10,488 in the constipation group and 10,516 in the diarrhea group. Multiple regression showed that high-quality carbohydrates were negatively associated with constipation (OR: 0.852, 95% CI: 0.796–0.912, P = 0.0001). Low-quality carbohydrates were positively associated with constipation (OR: 1.010, 95% CI: 1.002–1.018, P = 0.0295). There was no significant direct association between carbohydrate quality and diarrhoea (P = 0.5189, P = 0.8278). Segmented regression results showed a non-significant association between low quality carbohydrate intake above 40.65 servings/day and constipation, while quality carbohydrate intake above 3.84 servings/day was not significantly associated with diarrhoea. Subgroup analyses showed differences in carbohydrate quality and constipation or diarrhoea across populations. Conclusions High-quality carbohydrates lowered constipation risk by 33.7% and reduced diarrhea risk with intake up to 3.84 servings/day. In contrast, low-quality carbohydrates increased constipation risk by 83.4%, with risk stabilizing beyond 40.65 servings/day. These effects varied across groups, suggesting that better carbohydrate quality supports gut health, especially in sensitive individuals.
Frontline management of mantle cell lymphoma
Abstract Despite many recent therapeutic advances, mantle cell lymphoma (MCL) remains a largely incurable disease. Treatments for patients with relapsed/refractory (R/R) disease are limited in number and in response durability. Therefore, improving the efficacy of frontline (1L) treatment, and specifically maximizing the duration of first remission, remains of critical importance to obtain favorable long-term outcomes. As 1L treatments become more effective, improving tolerability is also becoming an increasingly realistic goal. Targeted agents, which are now mainstays of treatment in R/R MCL, are establishing new, paradigm-changing roles in frontline treatment. Here, we review data supporting current standard-of-care approaches and explore 6 main areas of possible focus for advancement of 1L management: optimizing the chemoimmunotherapy (CIT) backbone, adding targeted agents to CIT, redefining the role of autologous stem cell transplantation, improving maintenance therapy, using targeted agent combinations with omission of CIT, and using measurable residual disease–guided therapy. We highlight several ongoing phase 3 trials that may soon impact frontline MCL management, and outline some areas of necessary investigation as the field continues to strive toward a cure for this disease.